newsfilter
← Latest News
GlobeNewswire·

BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier

  • BioStem Technologies Inc. added VENDAJE® and VENDAJE AC® to existing contracts with Vizient, Inc. & Premier, Inc., the two largest US Group Purchasing Organizations.
  • Products are available for order immediately under both contracts, marking the first GPO coverage for VENDAJE & VENDAJE AC.
  • The agreements remove barriers for clinicians in over 9,000 member hospitals (5,000+ for Vizient & 4,000+ for Premier) to access these BioRetain® wound care solutions.
  • VENDAJE is a placental-derived dehydrated allograft composed of the amnion layer, while VENDAJE AC is a thicker multilayer allograft retaining amnion, intermediate, & chorion layers.
  • Both products utilize BioStem's proprietary BioRetain® process to retain native placental tissue properties for soft tissue wound protection.
  • BioStem maintains AATB accreditation with quality systems compliant with cGTP & cGMP regulations.